Roderike Pohl, VP Research at Biodel Inc (BIOD), sold 10,000 shares at $19.72 ($197K) on 2007-12-17, disclosed to the SEC on 2007-12-18.
Scheduled sale ($197k) by VP Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.50 | 873 | $17K | 8.7% |
| 2 | $19.51 | 327 | $6K | 3.2% |
| 3 | $19.52 | 700 | $14K | 6.9% |
| 4 | $19.54 | 450 | $9K | 4.5% |
| 5 | $19.55 | 150 | $3K | 1.5% |
| 6 | $19.56 | 147 |
| $3K |
| 1.5% |
| 7 | $19.57 | 100 | $2K | 1.0% |
| 8 | $19.61 | 3 | $59 | 0.0% |
| 9 | $19.58 | 500 | $10K | 5.0% |
| 10 | $19.60 | 550 | $11K | 5.5% |
| 11 | $19.62 | 300 | $6K | 3.0% |
| 12 | $19.63 | 46 | $903 | 0.5% |
| 13 | $19.65 | 250 | $5K | 2.5% |
| 14 | $19.66 | 104 | $2K | 1.0% |
| 15 | $19.71 | 200 | $4K | 2.0% |
| 16 | $19.72 | 600 | $12K | 6.0% |
| 17 | $19.73 | 150 | $3K | 1.5% |
| 18 | $19.74 | 1,350 | $27K | 13.6% |
| 19 | $19.75 | 950 | $19K | 9.5% |
| 20 | $19.76 | 50 | $988 | 0.5% |
| 21 | $19.77 | 350 | $7K | 3.5% |
| 22 | $19.78 | 300 | $6K | 3.0% |
| 23 | $19.79 | 750 | $15K | 7.5% |
| 24 | $19.80 | 750 | $15K | 7.6% |
| 25 | $19.82 | 50 | $991 | 0.5% |
| Total | $19.67 avg | 10,000 | $197K | 100% |
| Filing → |
| BIOD | SELL | 2008-02-01 | $40K | — | Filing → |
| BIOD | SELL | 2008-01-31 | $20K | — | Filing → |
| BIOD | SELL | 2008-01-31 | $36K | — | Filing → |